Below is a comprehensive breakdown of the IPA/CJC (Ipamorelin / CJC-1295 No DAC) blend.

Product Overview & Key Features

This research blend is designed to investigate the synergistic signaling between two potent growth hormone secretagogues. By targeting distinct pathways, the combination is a primary focus for studies involving metabolic research and endocrine system modeling.

• Dual-Action Signaling: Combines a GHRH analogue (CJC-1295) with a GHRP (Ipamorelin) to mimic natural pulsatile release.
• High-Purity Standards: Laboratory-grade vials are typically HPLC/MS verified at ≥99% purity.
• Optimal Stability: Supplied as a lyophilized powder to ensure long-term chemical integrity during shipping and storage.
• Precision Research: Specifically formulated for in-vitro laboratory research and analytical applications.

Technical Specifications

For your technical data sheets and SEO metadata, use these precise chemical identifiers:

Available Configurations

These are the standard market configurations most frequently searched by laboratory procurement officers:

• 5mg/5mg Blend (10mg Total): The most common e-commerce configuration for standardized research.
• 6mg/6mg Blend (12mg Total): High-concentration vials for extended study protocols.
• Bulk Research Packs: Typically available in 5-vial or 10-vial kits for volume-based laboratory discounts.